Clinical trials show great results for tirzepatide users: Some patients lost up to 22.5% of their body weight
Additionally, there are specific side effects associated with injectable semaglutide, such as injection site reactions and potential cardiovascular risks
Ge L, Liu L, Liu H et al (2015) Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice
The 39% lean mass loss figure is an average from clinical trials where participants were not given specific exercise or supplementation protocols
When in doubt, discard and order a replacement through PlexusDx
Paquette M, El-Houjeiri L, C Zirden L, Puustinen P, Blanchette P, Jeong H, et al